The Asia Pacific Transfer Membrane Market would witness market growth of 5.6% CAGR during the forecast period (2022-2028).
In blotting techniques, the diffusion of proteins from a gel matrix and their absorption by the transfer membrane is necessary to transfer molecules. The concentration gradient that pushes proteins toward the membrane is maintained because the absorbed proteins are "removed" from the solution. Diffusion blotting, first used to transfer proteins from IEF (isoelectric focusing) gels, is also effective for other macromolecules, particularly nucleic acids.
The best usage of diffusion blotting is for producing several immunoblots from a single gel. Blots made with this technique may also be used to evaluate proteins using zymography and mass spectrometry to identify them. Protein recoveries are generally 25–50% of the total transferable protein compared to other transfer techniques. Protein transport is also not quantitative. Very large proteins in SDS-PAGE gels may be challenging to transfer using diffusion blotting, although smaller proteins are often transferred without issue.
In Australia, chronic problems account for most illnesses, disabilities, and fatalities. The Australian Institute of Health and Welfare provides statistics regarding chronic diseases. They discuss eight prevalent diseases: diabetes, cancer, cardiovascular disease, chronic obstructive pulmonary disease, back pain, arthritis, asthma, and mental health issues. These eight frequent diseases significantly influence Australians since one in two (50%) and three in five (60%) of those over 65 have at least one, and nine out of ten fatalities are linked to them. The growing prevalence of chronic diseases in the region will surge the requirement for transfer membrane for diagnosis and therefore boost the market growth in the region.
The China market dominated the Asia Pacific Transfer Membrane Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $31,847.4 Thousands by 2028. The Japan market is estimated to grow a CAGR of 5% during (2022 - 2028). Additionally, The India market would experience a CAGR of 6.3% during (2022 - 2028).
Based on Product, the market is segmented into PVDF, Nitrocellulose and Nylon. Based on Transfer Method, the market is segmented into Dry Electro Blotting (Dry Transfer), Semi-dry Electro Blotting (Semi-dry Transfer), Wet or Tank Transfer and Others. Based on Application, the market is segmented into Western Blotting, Southern Blotting, Northern Blotting and Others. Based on End-User, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, Academic & Research Institutes and Diagnostic Labs. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Transfer Membrane Market is Projected to reach USD 418.9 Million by 2028, at a CAGR of 4.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, PerkinElmer, Inc., Abcam Plc, Santa Cruz Biotechnology, Inc., ATTO Corporation, Azure Biosystems, Inc., and GVS S.p.A.
By Product
By Transfer Method
By Application
By End-User
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 